Warwick spinout Medherant is pleased to announce preliminary results of trials of its testosterone patch for post menopausal women.

Cytoswim has received clearance from the U.S. Food and Drug Administration (FDA) for its novel SpermAlign device which helps select high quality sperm for use in Assistive Reproductive Techniques.